Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2020, Vol. 40 Issue (9): 1-10    DOI: 10.13523/j.cb.2005059
    
The Study on the Effect of NS2A-C60A Site Mutation of Japanese Encephalitis Virus on Its Biological Characteristics
GUO Guang-chao1,ZHOU Yu-yong1,CAO San-jie1,2,3,**(),WU Yao-min1,WU Rui1,ZHAO Qin1,WEN Xin-tian1,HUANG Xiao-bo1,WEN Yi-ping1
1 Research Center for Swine Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China
2 National Teaching and Experiment Center of Animal, Sichuan Agricultural University, Chengdu 611130, China
3 Sichuan Science-observation Experimental Station of Veterinary Drugs and Veterinary Diagnostic Technology, sMinistry of Agriculture, Chengdu 611130, China
Download: HTML   PDF(12541KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: In order to explore the effect of the NS2A-C60A gene mutation in the attenuation process on the biological characteristics of Japanese encephalitis virus. Method: First of all, the target research site NS2A-C60A that may be related to the expression of NS1' and virulence weakening was determined by sequencing and comparison of the genomes of the JEV attenuated strain and the original strain, prediction of the secondary structure of the 5'-terminal sequence of NS2A gene, and changes in NS1' protein expression; then, the NS2A-C60A single point mutation virus strain rJEV-C60A was rescued by using reverse genetic site-directed mutation technology; Finally, the influences on the biological characteristics for JEV were studyed by the observation of plaque morphology, growth curve, dual luciferase analysis, WB, inflammatory factor detection and animal experiments. Results: The research found for the first time that the passage attenuated of type Ⅰ JEV would lead to a significant decrease in NS1' protein expression and the related site NS2A-C60A, and successfully rescued the NS2A-C60A single point mutant strain rJEV-C60A. Plaque and growth curve results show that the NS2A-C60A mutation have no effect on the growth characteristics of JEV, but dual luciferase analysis and WB results reveal that NS2A-C60A mutation can significantly reduce the expression of viral NS1' protein. The results of inflammatory factors suggeset that the NS2A-C60A site mutation can slightly hinder the JEV suppression of inflammatory factors expression, but animal experiments show that the NS2A-C60A point mutation virus has similar neurovirulence to the original strain, indicating that the site mutation is not a key site that affects the virulence of JEV. Conclusion: The novel mutation NS2A-C60A can significantly reduce the expression of the JEV NS1' protein, but it has no significant effects on its other biological characteristics, like proliferation, induced inflammation and neurovirulence.



Key wordsJapanese encephalitis virus      Passage attenuation      NS2A-C60A point mutation      NS1' protein      Biological characteristics     
Received: 27 May 2020      Published: 12 October 2020
ZTFLH:  Q819  
Corresponding Authors: San-jie CAO     E-mail: veterinary226@163.com
Cite this article:

GUO Guang-chao,ZHOU Yu-yong,CAO San-jie,WU Yao-min,WU Rui,ZHAO Qin,WEN Xin-tian,HUANG Xiao-bo,WEN Yi-ping. The Study on the Effect of NS2A-C60A Site Mutation of Japanese Encephalitis Virus on Its Biological Characteristics. China Biotechnology, 2020, 40(9): 1-10.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2005059     OR     https://manu60.magtech.com.cn/biotech/Y2020/V40/I9/1

Fig.1 The map of the target research site NS2A-C60A determined (a) F1 and F120 generation NS1' protein WB (b) NS2A gene sequence alignment (c) NS2A gene secondary structure prediction
Fig.2 The map of the target research site NS2A-C60A determined (a) F1 and F120 generation NS1' protein WB (b) NS2A gene sequence alignment (c) NS2A gene secondary structure prediction
Fig.3 Plaque morphology of the original strain rJEV-WT and the single point mutant strain rJEV-C60A rJEV-WT: Original strain; rJEV-C60A: NS2A-C60A point mutation strain(rescued)
Fig. 4 Growth curve detection results of the original strain rJEV-WT and the single point mutant strain rJEV-C60A
Fig.5 The effect of NS2A-C60A point mutation on dual luciferase activity *P<0.05
Fig.6 WB detection results of NS1 'protein expression of the original strain rJEV-WT and the single point mutant strain rJEV-C60A *P<0.05
Fig.7 The detection results of inflammatory factors TNF-α, CCL-2, IL-6 and IFN-beta by using qRT-PCR ns:P>0.05
Fig.8 Neurovirulence test results of the original strain rJEV-WT and the point mutant strain rJEV-C60A
[1]   张海林, 自登云, 龚正达. 云南省乙型脑炎病毒宿主和媒介研究. 中国预防兽医学报, 2000,22(2):81-83.
[1]   Zhang H L, Zi D Y, Gong Z D. Host and vector of Japanese encephalitis virus in Yunnan province,China. Chinese Journal of Preventive Veterinary Medicine, 2000,22(2):81-83.
[2]   张海林, 张云智, 黄文丽, 等. 蝙蝠作为流行性乙型脑炎病毒宿主的研究. 动物医学进展, 2002,23(5):58-61.
[2]   Zhang H L, Zhang Y Z, Huang W L, et al. The study on bat as a host of Japanese encephalitis virus,China. Chinese Progress in Animal Medicine, 2002,23(5):58-61.
[3]   Lord J S, Gurley E S, Pulliam J R. Rethinking Japanese encephalitis virus transmission: a framework for implicating host and vector species. PLoS Negl Trop Dis, 2015,9(12):e0004074.
pmid: 26657648
[4]   Villordo S M, Gamarnik A V. Genome cyclization as strategy for flavivirus RNA replication, Virus Res, 2009,139(2):230-239.
pmid: 18703097
[5]   Sumiyoshi H, Mori C, Fuke I, et al. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA, Virology, 1987,161(2):497-510.
doi: 10.1016/0042-6822(87)90144-9 pmid: 3686827
[6]   Tsai T F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine, 2000,18(Suppl 2):1-25.
[7]   Mcarthur M A, Holbrook M R. Japanese encephalitis vaccines. Journal of Bioterrorism and Biodefense, 2011,2011(1):2.
[8]   Ding D, Hong Z, Zhao S J, et al. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg, 2007,77(3):528-533.
pmid: 17827373
[9]   Lindenbach B D, Rice C M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol, 1997,71(12):9608-9617.
doi: 10.1128/JVI.71.12.9608-9617.1997 pmid: 9371625
[10]   Winkelmann E R, Widman D G, Suzuki R, et al. Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1. Virology, 2011,421(2):96-104.
pmid: 21999990
[11]   Avirutnan P, Zhang L, Punyadee N, et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog, 2007,3(11):e183.
doi: 10.1371/journal.ppat.0030183 pmid: 18052531
[12]   Chung K M, Nybakken G E, Thompson B S, et al. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol, 2006,80(3):1340-1351.
pmid: 16415011
[13]   Muller D A, Young P R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res, 2013,98(2):192-208.
doi: 10.1016/j.antiviral.2013.03.008 pmid: 23523765
[14]   Firth A E, Atkins J F. A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting. Virol J, 2009,6(1):14.
[15]   Young L B, Melian E B, Khromykh A A. NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication. J Virol, 2013,87(16):9384-9390.
[16]   Melian E B, Hinzman E, Nagasaki T, et al. NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol, 2010,84(3):1641-1647.
pmid: 19906906
[17]   Sun J, Yu Y, Deubel V. Japanese encephalitis virus NS1' protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis. Microbes Infect, 2012,14(11):930-940.
pmid: 22504173
[18]   Ye Q, Li X F, Zhao H, et al. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation. J Gen Virol, 2012,93(Pt 9):1959-1964.
pmid: 22739060
[19]   Yun S I, Lee Y M. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother, 2014,10(2):263-279.
pmid: 24161909
[20]   Jiang R, Ye J, Zhu B, et al. Roles of TLR3 and RIG-I in mediating the inflammatory response in mouse microglia following Japanese encephalitis virus infection. Journal of Immunology Research, 2014,2014:787023.
pmid: 25101306
[21]   Yun S I, Song B H, Polejaeva I A, et al. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo. J Gen Virol, 2016,97(10):2575-2591.
pmid: 27498826
[22]   Cao J X, Ni H, Wills M R, et al. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. J Gen Virol, 1995,76(Pt 11):2757-2764.
[23]   Yu Y X, Wu P F, Ao J, et al. Selection of a better immunogenic and highly attenuated live-vaccine virus strain of Japanese B encephalitis. I. Some biological characteristics of SA sub (14)-14-2 mutant. Chinese Journal of Microbiology and Immunology, 1981,1(2):77-83.
[24]   Ao J, Yu Y, Tang Y, et al. Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. II. Safety and immunogenicity of live vaccine SA14-14-2 observed in inoculated children. Chin J Microbiol Immunol, 1983,3:245-248.
[25]   Melian E B, Edmonds J H, Nagasaki T K, et al. West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response. J Gen Virol, 2013,94(Pt 2):308-313.
pmid: 23114626
[26]   Melian E B, Hall-Mendelin S, Du F, et al. Programmed ribosomal frameshift alters expression of west nile virus genes and facilitates virus replication in birds and mosquitoes. PLoS Pathog, 2014,10(11):e1004447.
[1] WANG Dian-liang. The Types and Biological Characteristics of Cell Drug[J]. China Biotechnology, 2016, 36(5): 138-144.
[2] GUO Yang, LIN Hua. The New Development of Japanese Encephalitis Vaccine and Vaccine Research[J]. China Biotechnology, 2015, 35(10): 66-71.
[3] XIN Yi, GONG Da, XI Xin, SHI Hong-tao, LIU Sa, XU Xiu-fang, LI Na, HUANG Yi-min. Combined Enzymatic Digestion Method and Explants Culture Method Used on Primary Culture and Biological Characteristic Identification of Pulmonary Artery Smooth Muscle Cells of mice[J]. China Biotechnology, 2013, 33(9): 10-16.
[4] ZHAO Yu-jiao, PAN Yue, YAN Ling-mei, YUE Yao-fei, YANG Li-juan, SUN Qiang-ming. Adaptability of Dengue-Ⅱ Virus D01090 Strain in KMB17 Cells and Its Preliminary Identification[J]. China Biotechnology, 2012, 32(11): 1-7.
[5] ZHAO Yu-jiao, PAN Yue, YAN Ling-mei, YUE Yao-fei, YANG Li-juan, SUN Qiang-ming. Adaptability of Dengue-Ⅱ Virus D01090 Strain in KMB17 Cells and Its Preliminary Identification[J]. China Biotechnology, 2012, 32(11): 1-7.
[6] HOU Xiao-Qiang Xian-Zhu XIA. Molecular Cloning, Prokaryotic Expression, and Biological Activity of α-2,6 Sialyltransferase[J]. China Biotechnology, 2009, 29(01): 17-22.